Walid I. Saliba

ORCID: 0000-0003-3324-8611
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Arrhythmias and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Cardiac pacing and defibrillation studies
  • Cardiac electrophysiology and arrhythmias
  • Cardiac Imaging and Diagnostics
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac Structural Anomalies and Repair
  • Cardiovascular Function and Risk Factors
  • Cardiovascular Effects of Exercise
  • Cardiac Valve Diseases and Treatments
  • Cardiac tumors and thrombi
  • Cardiovascular Syncope and Autonomic Disorders
  • Health Systems, Economic Evaluations, Quality of Life
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Viral Infections and Immunology Research
  • Cardiomyopathy and Myosin Studies
  • Infective Endocarditis Diagnosis and Management
  • Cardiovascular Disease and Adiposity
  • Parathyroid Disorders and Treatments
  • Transplantation: Methods and Outcomes
  • Mechanical Circulatory Support Devices
  • Electrostatic Discharge in Electronics
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Pericarditis and Cardiac Tamponade
  • Cardiovascular and Diving-Related Complications

Cleveland Clinic
2016-2025

Carmel Medical Center
2016-2025

Technion – Israel Institute of Technology
2016-2025

Orthopedic Institute
2021-2024

Agaplesion Markus Hospital
2024

Clalit Health Services
2016-2023

Rappaport Family Institute for Research in the Medical Sciences
2022

Stanford University
2007-2019

University of Pittsburgh Medical Center
2019

Diabetes Canada
2019

Treatment with antiarrhythmic drugs and anticoagulation is considered first-line therapy in patients symptomatic atrial fibrillation (AF). Pulmonary vein isolation (PVI) radiofrequency ablation may cure AF, obviating the need for anticoagulation.To determine whether PVI feasible as treating AF.A multicenter prospective randomized study conducted from December 31, 2001, to July 1, 2002, of 70 aged 18 75 years who experienced monthly AF episodes at least 3 months had not been treated...

10.1001/jama.293.21.2634 article EN JAMA 2005-05-31

Pulmonary-vein isolation is increasingly being used to treat atrial fibrillation in patients with heart failure.In this prospective, multicenter clinical trial, we randomly assigned symptomatic, drug-resistant fibrillation, an ejection fraction of 40% or less, and New York Heart Association class II III failure undergo either pulmonary-vein atrioventricular-node ablation biventricular pacing. All completed the Minnesota Living Failure questionnaire (scores range from 0 105, a higher score...

10.1056/nejmoa0708234 article EN New England Journal of Medicine 2008-10-22

The objective of this study was to assess the impact intracardiac echocardiography (ICE) on long-term success and complications in patients undergoing pulmonary vein isolation (PVI) for treatment atrial fibrillation (AF).Three hundred fifteen underwent PVI AF. Each patient ostial all PVs using a cooled-tip ablation catheter. performed circular mapping (CM) alone (group 1, 56 patients), CM ICE 2, 107 with titration radiofrequency energy based visualization microbubbles by 3, 152 patients)....

10.1161/01.cir.0000070541.83326.15 article EN Circulation 2003-05-20

Background— The role of pulmonary vein (PV) isolation in ablative treatment atrial fibrillation (AF) has been debated conflicting reports. We sought to compare PV conduction patients who had no AF recurrence (group I), could maintain sinus rhythm on antiarrhythmic medication II), and recurrent despite III) after antrum (PVAI). Methods Results— was examined consecutive undergoing second PVAI for recurrence. also recruited some cured undergo a repeat, limited electrophysiological study at...

10.1161/circulationaha.104.533190 article EN Circulation 2005-08-02

Effects of contact force (CF) on lesion formation during pulsed field ablation (PFA) have not been well validated. The purpose this study was to determine the relationship between average CF and size PFA using a swine-beating heart model.

10.1161/circep.123.012026 article EN Circulation Arrhythmia and Electrophysiology 2023-12-28

Pulmonary vein (PV) stenosis is a complication of ablation for atrial fibrillation. The impact different strategies on the incidence PV and its functional characterization has not been described.PV isolation was performed in 608 patients. An electroanatomic approach used 71 circular mapping 537 (distal isolation, 25; ostial based angiography, 102; guided by intracardiac echocardiography, 140; with energy delivery visualization microbubbles, 270). Severe (> or =70%) narrowing detected 21...

10.1161/01.cir.0000104569.96907.7f article EN Circulation 2003-11-18

Background —Standard mapping and ablation of focal sources atrial fibrillation are associated with very long procedure times low efficacy. An anatomic approach to complete pulmonary vein isolation could overcome these limitations. Methods Results —Fifteen patients refractory medication underwent circumferential the veins by using a novel catheter, an ultrasound transducer (8-MHz) mounted near tip, in saline-filled balloon. Twelve foci and/or triggers were identified 9 (pulmonary locations:...

10.1161/01.cir.102.16.1879 article EN Circulation 2000-10-17

Pulmonary vein isolation is a new, effective curative procedure for selected patients with atrial fibrillation. stenosis potential complication and may lead to symptoms that are often underrecognized.To describe the clinical course associated pulmonary developing after ablation in veins.Retrospective study.Tertiary care referral center.335 referred catheter of drug-refractory fibrillation.Pulmonary electrical using radiofrequency ablation.Three months ablation, underwent routine screening...

10.7326/0003-4819-138-8-200304150-00010 article EN Annals of Internal Medicine 2003-04-15

Background— The best approach to management of anticoagulation before and after atrial fibrillation ablation is not known. Methods Results— We compared outcomes in consecutive patients undergoing pulmonary vein antrum isolation for persistent fibrillation. Early our practice, warfarin was stopped 3 days ablation, a transesophageal echocardiogram performed rule out clot. Enoxaparin, initially 1 mg/kg twice daily (group 1) then 0.5 2), used “bridge” ablation. Subsequently, continued maintain...

10.1161/circulationaha.107.727784 article EN Circulation 2007-11-13

Background— Left atrioesophageal fistula is a rare but devastating complication that may occur after catheter ablation of atrial fibrillation. We used capsule endoscopy to assess esophageal injury for fibrillation in population randomized undergo general anesthesia or conscious sedation. Methods and Results— Fifty patients undergoing paroxysmal symptomatic refractory antiarrhythmic drugs were enrolled randomized, including those the procedure under (25 patients, group 1) receiving sedation...

10.1161/circep.108.815266 article EN Circulation Arrhythmia and Electrophysiology 2009-02-14

The epicardial location of an arrhythmia could be responsible for unsuccessful endocardial catheter ablation.In 48 patients referred after prior ablation, we considered percutaneous, subxiphoid instrumentation the pericardial space mapping and ablation. Thirty had ventricular tachycardia (VT), 6 a right- 4 left-sided accessory pathway (AP), inappropriate sinus tachycardia, atrial arrhythmias. Of 30 VTs, 24 (6 with ischemic cardiomyopathy, 3 idiopathic 15 normal hearts) appeared to originate...

10.1161/01.cir.0000087407.53326.31 article EN Circulation 2003-09-09

Ablation of atrial fibrillation is generally considered safe and effective. However, atrial-esophageal fistulas have recently been reported as a rare but fatal complication.To describe 9 patients with after ablation for fibrillation.Retrospective case series.Institutions where cardiologists performed procedures.9 ablation.Demographic characteristics, mortality, presenting signs symptoms, days to presentation.Patients presented mean 12.3 (range, 10 16 days) their procedures. Nonspecific...

10.7326/0003-4819-144-8-200604180-00007 article EN Annals of Internal Medicine 2006-04-18

Left atrioesophageal fistula is a devastating complication of atrial fibrillation ablation. There no standard approach for avoiding this complication, which caused by thermal injury during The objectives study were to evaluate the course esophagus and temperature within pulmonary vein antrum isolation (PVAI) correlate these data with tissue damage.Eight-one patients presenting PVAI underwent evaluation that included probe placement. Esophagus was obtained computed tomography, 3D imaging...

10.1161/circulationaha.104.509612 article EN Circulation 2005-07-19
Coming Soon ...